Neumora Therapeutics, Inc.

NMRA · Biological Products, (No Diagnostic Substances)
6
Directors
60
Avg Age
5.0
Avg Tenure (yrs)
83%
Independent
Independent Non-independent Near rotation

Board Members

PB
Paul L. Berns Chair
AH
Alaa Halawa Director

...and 4 more directors

The full roster, committee assignments, director pay, and expected-turnover signals for every board on the site are in our free newsletter, Seats Opening.

Get Seats Opening

Source: SEC DEF 14A proxy statement filed 2026-04-17. Data extracted and structured by FindABoardSeat.